Cancer is now viewed as a systems biology disease, and oral squamous cell carcinoma (OSCC) can be viewed in a similar fashion. In this paper, we highlight some of the novel molecular events in OSCC, revealed through an integrative strategy of systems biology based on high-throughput omics analysis such as genomics and/or proteomics, the most powerful hypothesis-generating means available today. These approaches have resulted not only in the identification of novel genes for OSCC, but also in more comprehensive networks that describe the mechanisms by which those identified events work, with the promise of developing this knowledge into biomarkers for diagnosis, prognosis, and prediction of therapeutic responses in OSCC patients. Long-term, population-based prospective studies of OSCC patients, and those at high risk of developing OSCC, will then be needed to validate these biomarkers.
AlevizosIMahadevappaMZhangXOhyamaHKohnoYPosnerM. (2001). Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene20:6196-6204.
2.
ArgonYSimenBB (1999). GRP94, an ER chaperone with protein and peptide binding properties. Semin Cell Dev Biol10:495-505.
3.
BenelliRLorussoGAlbiniANoonanDM (2006). Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des12:3101-3115.
4.
BijianKMlynarekAMBalysRLJieSXuYHierMP. (2009). Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. J Proteome Res8:2173-2185.
5.
BoehmUKlampTGrootMHowardJC (1997). Cellular responses to interferon-γ. Annu Rev Immunol15:749-795.
6.
ChambersTJ (2000). Regulation of the differentiation and function of osteoclasts. J Pathol192:4-13.
7.
ChaturvediAKEngelsEAAndersonWFGillisonML (2008). Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol26:612-619.
8.
ChenCMendezEHouckJFanWLohavanichbutrPDoodyD. (2008). Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev17:2152-2162.
9.
ChiLMLeeCWChangKPHaoSPLeeHMLiangY. (2009). Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS. Mol Cell Proteomics8:1453-1474.
10.
ChoiSMyersJN (2008). Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res87:14-32; erratum in J Dent Res 87:191, 2008.
11.
CravenRABanksRE (2001). Laser capture microdissection and proteomics: possibilities and limitation. Proteomics1:1200-1204.
FranzmannEJReateguiEPPedrosoFPernasFGKarakullukcuBMCarrawayKL. (2007). Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev16:1348-1355.
14.
FunkGFKarnellLHRobinsonRAZhenWKTraskDKHoffmanHT (2002). Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck24:165-180.
15.
GourinCGXiaZSHanYFrenchAMO’RourkeAKTerrisDJ. (2006). Serum protein profile analysis in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg132:390-397.
16.
GrottkauBEChenXRFriedrichCCYangXMJingWWuYCaiXXLiuYRHuangYDLinYF (2009). DAPT enhances the apoptosis of human tongue carcinoma cells. Int J Oral Sci1(2):81-89.
17.
GrundmannOMitchellGCLimesandKH (2009). Sensitivity of salivary glands to radiation: from animal models to therapies. J Dent Res88:894-903.
18.
HajkovaDRaoKCMiyagiM (2006). pH dependency of the carboxyl oxygen exchange reaction catalyzed by lysyl endopeptidase and trypsin. J Proteome Res5:1667-1673.
19.
HanahanDWeinbergRA (2000). The hallmarks of cancer. Cell100:57-70.
20.
HeQYChenJKungHFYuenAPChiuJF (2004). Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics4:271-278.
21.
HennesseyPTWestraWHCalifanoJA (2009). Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res88:300-306.
22.
HensonDESrivastavaSKramerBS (1999). Molecular and genetic targets in early detection. Curr Opin Oncol11:419-425.
23.
HerrmannPCLiottaLAPetricoinEF3rd (2001). Cancer proteomics: the state of the art. Dis Markers17:49-57.
24.
HinestrosaMCDickersinKKleinPMayerMNossKSlamonD. (2007). Shaping the future of biomarker research in breast cancer to ensure clinical relevance. Nat Rev Cancer7:309-315.
25.
HiroiMMoriKSekineKSakaedaYShimadaJOhmoriY (2009). Mechanisms of resistance to interferon-gamma-mediated cell growth arrest in human oral squamous carcinoma cells. J Biol Chem284:24869-24880.
26.
HoodBLDarflerMMGuielTGFurusatoBLucasDARingeisenBR. (2005). Proteomic analysis of formalin-fixed prostate cancer tissue. Mol Cell Proteomics4:1741-1753.
27.
HornbergJJBruggemanFJWesterhoffHVLankelmaJ (2006). Cancer: a systems biology disease. Biosystems83:81-90.
28.
HuSArellanoMBoontheungPWangJZhouHJiangJ. (2008). Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res14:6246-6252.
29.
HuangXWeiYLiLWenYYangJLiuB. (2006). Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncol42:26-31.
30.
IshikawaTNakashiroKHaraSKlosekSKLiCShintaniS. (2006). CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma. Int J Oncol28:61-66.
31.
JacobRJCramerR (2006). PIGOK: linking protein identity to gene ontology and function. J Proteome Res5:3429-3432.
32.
JewettAHeadCCacalanoNA (2006). Emerging mechanisms of immunosuppression in oral cancers. J Dent Res85:1061-1073.
33.
JungDWCheZMKimJKimKKimKYWilliamsD (2009). Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int J Cancer127:322-344.
34.
KayamoriKSakamotoKNakashimaTTakayanagiHMoritaKOmuraK. (2010). Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells. Am J Pathol176:968-980.
35.
KitanoH (2002). Systems biology: a brief overview. Science295:1662-1664.
36.
KlussmannJPWeissenbornSJWielandUDriesVEckelHEPfisterHJ. (2003). Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?Med Microbiol Immunol192:129-132.
37.
KoehnJKrapfenbauerKHuberSSteinESutterWWatzingerF. (2008). Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis. J Proteome Res7:3818-3829.
38.
LaubenbacherRHowerVJarrahATortiSVShulaevVMendesP. (2009). A systems biology view of cancer. Biochim Biophys Acta1796:129-139.
39.
LeeJIJinBHKimMAYoonHJHongSPHongSD (2009). Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod107:678-684.
40.
LiuET (2005). Systems biology, integrative biology, predictive biology. Cell121:505-506.
41.
LoWYLaiCCHuaCHTsaiMHHuangSYTsaiCH. (2007a). S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J Proteome Res6:2143-2151.
42.
LoWYTsaiMHTsaiYHuaCHTsaiFJHuangSY. (2007b). Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta376:101-107.
43.
LockwoodWWChariRChiBLamWL (2006). Recent advances in array comparative genomic hybridization technologies and their applications in human genetics. Eur J Hum Genet14:139-148.
MelleCErnstGSchimmelBBleulAKoscielnySWiesnerA. (2004). A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res64:4099-4104.
46.
MelleCBogumilRErnstGSchimmelBBleulAvon EggelingF (2006). Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling. Proteomics6:2600-2608.
47.
MelleCErnstGWinklerRSchimmelBKlussmannJPWittekindtC. (2009). Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue. Proteomics9:2193-2201.
48.
MendezEHouckJRDoodyDRFanWLohavanichbutrPRueTC. (2009). A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival. Clin Cancer Res15:1353-1361.
49.
MiyagiMRaoKC (2007). Proteolytic 18O-labeling strategies for quantitative proteomics. Mass Spectrom Rev26:121-136.
50.
MuckeTHolzleFWagenpfeilSWolffKDKestingM (2010). The role of tumor invasion into the mandible of oral squamous cell carcinoma. J Cancer Res Clin Oncol [Epub ahead of print, March 31, 2010] (in press).
51.
MulliganJKDayTAGillespieMBRosenzweigSAYoungMR (2009). Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions. Hum Immunol70:375-382.
52.
NagarajNS (2009). Evolving ‘omics’ technologies for diagnostics of head and neck cancer. Brief Funct Genomic Proteomic8:49-59.
53.
NaglerRBaharGShpitzerTFeinmesserR (2006). Concomitant analysis of salivary tumor markers—a new diagnostic tool for oral cancer. Clin Cancer Res12:3979-3984.
54.
Nazmul-HossainANPatelKJRhodusNLMoserKL (2008). Microarrays: applications in dental research. Oral Dis14:25-29.
55.
NeivaKGZhangZMiyazawaMWarnerKAKarlENörJE (2009). Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia11:583-593.
56.
NomuraHUzawaKYamanoYFushimiKIshigamiTKatoY. (2007). Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis. Br J Cancer97:792-801.
57.
O’DonnellRKKupfermanMWeiSJSinghalSWeberRO’MalleyB. (2005). Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene24:1244-1251.
58.
OngSEMannM (2006). A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc1:2650-2660.
59.
OngSEBlagoevBKratchmarovaIKristensenDBSteenHPandeyA. (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics1:376-386.
60.
PandruvadaSNYuvarajSLiuXSundaramKShanmugarajanSRiesWL. (2010). Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice. Int J Cancer126:2319-2329.
61.
ParkinDM (2001). Global cancer statistics in the year 2000. Lancet Oncol2:533-543.
62.
PatelVHoodBLMolinoloAALeeNHConradsTPBraistedJC. (2008). Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res14:1002-1014.
63.
PepeMSEtzioniRFengZPotterJDThompsonMLThornquistM. (2001). Phases of biomarker development for early detection of cancer. J Natl Cancer Inst93:1054-1061.
64.
PestkaSLangerJAZoonKCSamuelCE (1987). Interferons and their actions. Annu Rev Biochem56:727-777.
65.
RansohoffRM (2009). Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity31:711-721.
RehmanAOWangCY (2008). SDF-1alpha promotes invasion of head and neck squamous cell carcinoma by activating NF-kappaB. J Biol Chem283:19888-19894.
68.
RehmanAOWangCY (2009). CXCL12/SDF-1α activates NF-κB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex. Int J Oral Sci1:105-118.
69.
ReimersNKasperHUWeissenbornSJStutzerHPreussSFHoffmannTK. (2007). Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer120:1731-1738.
70.
RubinJB (2009). Chemokine signaling in cancer: one hump or two?Semin Cancer Biol19:116-122.
71.
SawyersCL (2008). The cancer biomarker problem. Nature452:548-552.
72.
SchadtEEZhangBZhuJ (2009). Advances in systems biology are enhancing our understanding of disease and moving us closer to novel disease treatments. Genetica136:259-269.
73.
ShiioYAebersoldR (2006). Quantitative proteome analysis using isotope-coded affinity tags and mass spectrometry. Nat Protoc1:139-145.
74.
ShinrikiSJonoHOtaKUedaMKudoMOtaT. (2009). Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma. Clin Cancer Res15:5426-5434.
75.
SidranskyDIrizarryRCalifanoJALiXRenHBenoitN. (2003). Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer patients from control subjects. J Natl Cancer Inst95:1711-1717.
76.
SoltysSGLeQTShiGTibshiraniRGiacciaAJKoongAC (2004). The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res10:4806-4812.
77.
SuzukiEImotoIPimkhaokhamANakagawaTKamataNKozakiKI. (2007). PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene26:7921-7932.
78.
TangCHChuangJYFongYCMaaMCWayTDHungCH (2008). Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kB pathways and promotes osteoclastogenesis in human oral cancer cells. Carcinogenesis29:1483-1492.
79.
TangDGContiCJ (2004). Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization: an update. Semin Thromb Hemost30:109-117.
80.
TavassoliMBrunelNMaherRJohnsonNWSoussiT (1998). p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int J Cancer78:390-391.
81.
TeicherBAFrickerSP (2010). CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res16:2927-2931.
82.
TurhaniDKrapfenbauerKThurnherDLangenHFountoulakisM (2006). Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis27:1417-1423.
83.
UnwinRDSternbergDWLuYPierceAGillilandDGWhettonAD (2005). Global effects of BCR/ABL and TEL/PDGFRbeta expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL. J Biol Chem280:6316-6326.
84.
WangZJiangLHuangCLiZChenLGouL. (2008). Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics7:1639-1650.
85.
WangZFengXLiuXJiangLZengXJiN. (2009a). Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis. BMC Genomics10:383.
86.
WangZZhangBJiangLZengXChenYFengX. (2009b). RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur J Cancer45:490-496.
87.
WengLPWuCCHsuBLChiLMLiangYTsengCP. (2008). Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility. J Proteome Res7:3765-3775.
88.
XieHOnsongoGPopkoJde JongEPCaoJCarlisJV. (2008). Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics7:486-498.
89.
YamaguchiM (2009). RANK/RANKL/OPG during orthodontic tooth movement. Orthod Craniofac Res12:113-119.
90.
YuvarajSGriffinACSundaramKKirkwoodKLNorrisJSReddySV (2009). A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells. Mol Cancer Res7:1399-1407.
91.
ZangLPalmer ToyDHancockWSSgroiDCKargerBL (2004). Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J Proteome Res3:604-612.
92.
ZhaoDXuQGChenXMFanMW (2009). Human papillomavirus as an independent predictor in oral squamous cell cancer. Int J Oral Sci1:119-125.
